Member Article

Onyx appointed to manage Cancer Research UK drug development projects

Sunderland-based Onyx Scientific has been appointed by Cancer Research UK to manage several of its drug development projects.

The contract research and manufacturing organisation is now supporting the charity across a portfolio of drug substance campaigns covering the development and manufacturing of active pharmaceutical ingredients (API) for use in clinical trials.

Cancer Research UK’s Drug Development Office initially selected the North-East based chemistry specialist for a project in 2011 and there have since been several further successful campaigns.

Onyx Scientific is now one of the Charity’s preferred providers for API development and GMP synthesis.

Dr Nigel Westwood, drug supply manager at Cancer Research UK, said: “Over the last few years, the team at Onyx Scientific has worked proactively with us on several challenging synthetic chemistry projects and provided exceptional value for money, which has led to us to select them for several new projects based on the company’s competitive costs and ability to deliver on time.

“Onyx Scientific is a reliable partner that can meet deadlines and deal with complex chemistry in a cost effective manner.“Â Â

Denise Bowser, commercial director at Onyx Scientific, said: “Our team has developed an excellent partnership with Cancer Research UK and so we are naturally delighted to be working with them on such a raft of important projects.“

This was posted in Bdaily's Members' News section by Ellen Forster .